Physician profile
Ancel J Rogers
NPI 1578673489
$2,591.96
in general payments reported to CMS, 2019-2025
19 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $530 · 2021: $556 · 2022: $379 · 2023: $275 · 2024: $538 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $915.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,751.34 | 2019-2025 | Collagenase Santyl, Pico 14, Regranex |
| Inari Medical, INC. | $183.89 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Vaporox, INC. | $124.24 | 2024 | Vht-200 Wound Treatment System |
| Abbvie INC. | $73.66 | 2023-2024 | Teflaro, Dalvance |
| Organogenesis INC. | $72.21 | 2020-2021 | |
| Medela LLC | $54.10 | 2020-2021 | |
| Kerecis Limited | $52.09 | 2021-2022 | |
| Trevena, INC. | $47.69 | 2021 | |
| Kci USA, INC. | $35.90 | 2020 | |
| Tactile Systems Technology INC | $35.82 | 2019-2020 | |
| Next Science LLC | $24.82 | 2022 | |
| Innocoll Pharmaceuticals Limited | $22.52 | 2022 | |
| Osiris Therapeutics INC. | $22.07 | 2019 | |
| Mimedx Group, INC. | $19.05 | 2025 | |
| Reprise Biomedical, INC. | $17.85 | 2025 | Miro3d |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $17.81 | 2024 | On-Q* Pump and Accessories |
| Hydrofera LLC | $12.99 | 2023 | Hydrofera Blue |
| Molnlycke Health Care US, LLC | $12.49 | 2025 | Mepilex Border Sacrum, Mepilex, Exufiber |
| Allergan, INC. | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ancel Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.